000 01492 a2200433 4500
005 20250515062027.0
264 0 _c20070718
008 200707s 0 0 eng d
022 _a0021-972X
024 7 _a10.1210/jc.2006-2865
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhosravi, Azarmindokht
245 0 0 _aDetermination of the elimination half-life of fibroblast growth factor-23.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cJun 2007
300 _a2374-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Intramural
650 0 4 _aAdult
650 0 4 _aBone Neoplasms
_xblood
650 0 4 _aFibroblast Growth Factor-23
650 0 4 _aFibroblast Growth Factors
_xblood
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOsteomalacia
_xblood
650 0 4 _aParaneoplastic Syndromes
_xblood
650 0 4 _aPostoperative Period
650 0 4 _aSoft Tissue Neoplasms
_xblood
650 0 4 _aTime Factors
700 1 _aCutler, Carolee M
700 1 _aKelly, Marilyn H
700 1 _aChang, Richard
700 1 _aRoyal, Richard E
700 1 _aSherry, Richard M
700 1 _aWodajo, Felasfa M
700 1 _aFedarko, Neal S
700 1 _aCollins, Michael T
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 92
_gno. 6
_gp. 2374-7
856 4 0 _uhttps://doi.org/10.1210/jc.2006-2865
_zAvailable from publisher's website
999 _c16929555
_d16929555